Icon Cancer Centre, Sunsuria Healthcare Partnership to Elevate Cancer Services in Malaysia

Kuala Lumpur, 14 September 2023 – Icon Cancer Centre, a global cancer care provider, and Sunsuria Healthcare, a subsidiary of Sunsuria Berhad, have announced a new joint venture entity, Icon Sunsuria Sdn Bhd (“Icon Sunsuria”), to expand the provision of high-quality cancer care across Malaysia. The partnership aims to enhance patient outcomes and advance cancer care clinical expertise, with a shared commitment to elevating the standard of cancer care for Malaysians.

According to the World Health Organisation (WHO), Malaysia saw an estimated 48,639 new cases of cancer in 2020, with this number expected to double by 2040. This is compounded by the country’s cancer survival rates, with research suggesting that for every five newly-diagnosed cases, there were three deaths from cancer within the same period.


Icon Sunsuria aims to provide access to quality cancer care and improve the well-being of patients and their families by establishing cancer centres across Malaysia via strategic partnerships with local healthcare operators. Leveraging Icon Cancer Centre’s long-standing excellence in oncology and deep network of clinical expertise, the joint venture will enrich the capability of hospitals’ existing medical services with specialized cancer expertise and enable patients to access comprehensive cancer care and cutting-edge treatments.

“Efforts such as these complement the Ministry’s own action plan for battling cancer, as outlined in the Malaysian National Strategic Plan for Cancer Control Program 2021-2025. In addition to improving the health of cancer survivors from diagnosis through to treatment, we welcome future-facing solutions that align with our strategic goals to address the country’s cancer research needs and strengthen our medical pool of talent,” said YB Dr. Zaliha Mustafa, Minister of Health Malaysia, when officiating the signing ceremony for the landmark partnership.

Icon Group delivers a comprehensive spectrum of services including medical oncology, radiation oncology, haematology, pharmacy, and chemotherapy compounding. As Australia’s leading integrated cancer care provider, the Group has grown its global footprint to encompass over 50 cancer centres across Australia, New Zealand, Mainland China, Hong Kong, Singapore and Vietnam, and has developed a robust remote training program offering ongoing training and skills development for oncology nurses.